Tender workspace

Tender Invitation for the Supply of Ceftolozane and Tazobactam for InfusionOriginal

Share tender

Hospital Authority · Tender Invitation for the Supply of Ceftolozane and Tazobactam for Infusion · Contract / tender number: HAHO(S)/T/26-D080 · Closed · Closing date: 2 November 2026 (12:00 noon Hong Kong time)

Tender information

Contract / tender number: HAHO(S)/T/26-D080
Closing date / Award: 2 November 2026 (12:00 noon Hong Kong time)
Contractor: —
Amount: —
Issuing organisation: 醫院管理局 Hospital Authority
Update: 3/11/2026 01:03:07

TENDER BRIEF · WITH SOURCES

Know the requirements. Plan your next step.

Hospital Authority Tender HAHO(S)/T/26-D080 for the supply of Ceftolozane and Tazobactam for Infusion (each vial contains 1g Ceftolozane Sulphate plus 0.5g Tazobactam Sodium, preservative free). Tender submissions must be in duplicate in hard copy enclosed in a sealed plain envelope, together with a CD-rom soft copy in text-searchable PDF of Tenderer’s Schedules B1 to B4 and the related documents; the closing time is 2026-11-02 12:00 noon. The bioequivalence studies report must compare against ZERBAXA or a brand that the Hospital Authority has used through Bulk Supplies Contracts, and must be conducted in accordance with WHO guidelines.

AI summary of the official notice and document excerpts obtained. The complete tender pack and all addenda have not been verified. Check the original terms.

Closing: 2026-11-02 12:00 noon (Hong Kong time)Official source ↗
Tender Method: Open tender (Tender Invitation), Hospital Authority Head OfficeOfficial source ↗

Scope of Work / Supply

Supply of Ceftolozane and Tazobactam for Infusion: each vial contains 1g Ceftolozane (Sulphate) and 0.5g Tazobactam (Sodium), preservative free.Official source ↗

The supply table lists 18,900 vials and two 27,000 vials figures on the same row, but no column headings are provided; they must not be added together or treated as the same batch, and the relationship is unconfirmed.Official source ↗

The initial term of the Contract is up to 36 months; the Hospital Authority may, by notice in writing before the expiry of the initial term, extend for an additional period of up to 24 months.Official source ↗

Eligibility Thresholds

A copy of the bioequivalence studies report must be submitted, comparing against the brand ZERBAXA or a brand that the Hospital Authority has used through Bulk Supplies Contracts.Official source ↗

Read the details before you decide.

No subscription required.

Related tenders

Related tenders from the same organisation

Other public records from the same department or category.